Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
114 participants
OBSERVATIONAL
2024-10-30
2025-10-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Descriptive Study of Circulating Gene or Protein Inflammatory Biomarkers and Bioimpedance Parameters in a Population of Patients Hospitalized for Decompensated Heart Failure With Preserved or Mildly Reduced Cardiac Function
NCT07320014
Biomarkers for Prognosis of Ambulatory Chronic Heart Failure Patients
NCT01113866
Biomarkers for the Assessment of Congestion in Patients With Ambulatory and Hospitalised Heart Failure
NCT06459999
Myocardial Mechanisms in Heart Failure With Preserved Ejection Fraction
NCT06517186
Serial Measurements of Biomarker in Patients With Acute Decompensated Heart Failure
NCT00514384
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
heart failure patients (HFrEF and HFpEF) without atrial fibrillation
Will be enrolled 57 patients with heart failure patients (HFrEF and HFpEF) without atrial fibrillation
Data collection
Given the observational nature of the study, the intervention is a simple data collection
heart failure patients (HFrEF and HFpEF) with atrial fibrillation
Will be enrolled 57 patients with heart failure patients (HFrEF and HFpEF) with atrial fibrillation
Data collection
Given the observational nature of the study, the intervention is a simple data collection
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Data collection
Given the observational nature of the study, the intervention is a simple data collection
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients with newly diagnosed or already treated heart failure (NYHA class II-IV) with HFrEF and HFpEF with and without atrial fibrillation.
* Patients who sign the consent to participate in the study
Exclusion Criteria
* Pregnant/breastfeeding women (verified by self-declaration)
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
IRCCS Ospedale Galeazzi-Sant'Ambrogio
Milan, Italy, Italy
IRCCS Galeazzi-Sant'Ambrogio
Milan, , Italy
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Fabrizio Dr. Colombo
Role: backup
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
BIOHF
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.